Literature Review
All posts tagged with “Clinical News | Disease Specific.”
Palliative external beam radiation therapy for dysphagia in a 101-year-old man with esophageal adenocarcinoma
02/14/26 at 03:15 AMPalliative external beam radiation therapy for dysphagia in a 101-year-old man with esophageal adenocarcinomaCureus; by Pericles J. Ioannides, Jester M. Odrunia, Gina N. Perez, Morgan Butow, Georg A. Weidlich; 1/26Esophageal adenocarcinoma in centenarians is rare, and treatment options in this age group are limited. We present the case of a 101-year-old male patient with symptomatic distal gastroesophageal junction (GEJ) adenocarcinoma who presented with progressive dysphagia, aspiration, and weight loss. The patient underwent palliative external beam radiation therapy (EBRT) ... targeting the obstructive esophageal mass with a margin using volumetric-modulated arc therapy (VMAT) technique. The treatment was well tolerated by the patient with no significant acute toxicity. After treatment, the patient reported clinically meaningful improvement in functional status, with improved swallowing, advancing from liquids to a soft diet, weight gain, and improved QoL. Moderate-dose palliative radiation can be a safe and effective treatment in a centenarian with obstructive GEJ adenocarcinoma, particularly when endoscopic interventions are not successful or durable.
[China] Progress in research on alleviating the symptoms associated with advanced cancer using Traditional Chinese Medicine
02/14/26 at 03:05 AM[China] Progress in research on alleviating the symptoms associated with advanced cancer using Traditional Chinese MedicinePain Research & Management; by Chunmeng Jiao, Ting Zhang, Yachen Yang, Ruofan Zhang, Wenbo Liu, Yanqing Wang, Lei Huang; 1/26Advanced cancer continues to pose a substantial global challenge, with complex symptom burdens and limited therapeutic options. Traditional Chinese Medicine (TCM), grounded in holistic theory and the principles of syndrome differentiation, employs interventions such as herbal medicine, acupuncture, moxibustion, and acupoint‐based therapies to address both the malignancy and the patient’s overall functional status. Emerging evidence indicates that TCM may alleviate symptom clusters associated with advanced cancer, enhance quality of life, and potentially contribute to improved survival outcomes. This review synthesizes findings from the past decade on the role of TCM in advanced cancer care, with a focus on herbal decoctions, Chinese herbal injections, acupuncture—either alone or in combination with herbal therapy—moxibustion with adjuvant medication, and other external TCM modalities. Evidence is examined regarding their effects on cancer‐related pain, fatigue, gastrointestinal dysfunction, chemotherapy‐ and radiotherapy‐induced toxicities, and immune modulation.
Advance care planning for patients with hematologic malignancies: A narrative review
02/14/26 at 03:05 AMAdvance care planning for patients with hematologic malignancies: A narrative reviewAmerican Journal of Hospice & Palliative Medicine; by Olivia M. Seecof; 1/26Advance care planning (ACP) completion rates are higher in patients with serious illness compared to the general population, however, ACP is overall under-utilized and sub-optimal, especially for patients with hematologic malignancies. This patient population can experience unique and significant physical and psychological symptoms due to their illness and the treatment, resulting in high rates of aggressive end of life care. This high healthcare utilization pattern often triggers ACP conversations and documentation, often facilitated by specialty palliative care clinicians. This review article examines existing literature about ACP for patients with hematologic malignancies with the intent to inform future prospective research to improve values-based patient care.
[Republic of Korea] P-1080. Multidrug-resistant organism status and its association with hospice use and end-of-life care patterns in patients with advanced cancer referred palliative care
02/14/26 at 03:00 AM[Republic of Korea] P-1080. Multidrug-resistant organism status and its association with hospice use and end-of-life care patterns in patients with advanced cancer referred palliative careOpen Forum Infectious Diseases; by Jeong-Han Kim, Jiwon Yu, Ye Sul Jeung, Shin Hye Yoo, Jin-ah Sim, Bhumsuk Keam; 1/26Multidrug-resistant organisms (MDRO) are increasingly prevalent and may contribute to more aggressive healthcare utilization near the end-of-life, particularly among patients with advanced cancer receiving palliative care (PC). MDRO status was associated with significantly lower use of community-based hospice care, including inpatient hospice ... and home hospice ... It was also linked to more frequent deaths in tertiary hospitals ... and higher intensive care unit admissions ... and renal replacement therapy ... Medical costs were consistently higher in the MDRO group across all end-of-life trajectory before death.
Community Hospice & Palliative Care unveils Advanced Cardiac Care Program
02/10/26 at 02:00 AMCommunity Hospice & Palliative Care unveils Advanced Cardiac Care Program Hospice News; by Jim Parker; 2/9/26 Florida-based Community Hospice & Palliative Care has launched an Advanced Cardiac Care Program to serve patients and families wrestling with heart disease. The hospice, an affiliate of Alivia Care, designed the program in collaboration with the American Heart Association (AHA) and the National Partnership for Healthcare and Hospice Innovation. It will provide a suite of services specifically designed for patients with cardiac conditions.
A scoping review on aphasia and technology: Exploring mechanisms enhancing quality of life
02/07/26 at 03:25 AMA scoping review on aphasia and technology: Exploring mechanisms enhancing quality of lifeQuality of Life Research; by Grace E. Terry, Cassondra Wilson, Gillian Anderson, Stacy M. Harnish; 1/26 People with aphasia are at an increased risk for reduced quality of life (QoL) because of their change in communication abilities. The present study aims to review the current evidence supporting assistive technology as a tool to improve QoL for people with aphasia, while investigating the various mechanisms technology may impact that lead to increased QoL for people with aphasia. This review emphasizes the role mechanisms such as self-management, social interaction, and virtual communication play in improving QoL for people with aphasia, while emphasizing the role technology plays in impacting the function of these mechanisms. However, for this assistive technology to be impactful, it must be person centered and thoroughly trained based on the current body of evidence.
EV0034 Palliative pain relief: A case study of high-frequency spinal cord stimulation in an end-of-life cancer patient
02/07/26 at 03:15 AMEV0034 Palliative pain relief: A case study of high-frequency spinal cord stimulation in an end-of-life cancer patientNeuromodulation: Technology at the Neural Interface; P. Majedi, Dominic Bailey; 1/26A significant proportion of patients with cancer will experience cancer-related pain at some point during their illness. The treatment approach for cancer-related pain is often multifaceted and may necessitate the use of advanced interventional methods, including spinal cord stimulation (SCS). Recent studies have demonstrated the utility and efficacy of SCS techniques in the treatment of cancer-related pain and chemotherapy induced neuropathy. Here, we present a case report on a patient receiving high frequency SCS at 10 kHz for end-stage cancer-related pain.
Many patients with advanced blood cancers delay hospice to keep access to blood transfusions
02/06/26 at 03:00 AMMany patients with advanced blood cancers delay hospice to keep access to blood transfusionManaged Healthcare Executive; by Briana Contreras; 2/4/26Key Takeaways:
DaVita’s strategic investment in Elara Caring aims to transform home-based kidney care
02/06/26 at 03:00 AMDaVita’s strategic investment in Elara Caring aims to transform home-based kidney care Market Chameleon; Press Release; 2/3/26 DaVita has announced a major new partnership, joining forces with Ares Management to invest in Elara Caring—one of the nation’s leading home health providers. ... A standout feature of this partnership is the plan for DaVita and Elara to co-develop a specialized, kidney-focused in-home care model. Leveraging DaVita’s expertise in kidney health and Elara’s reach in home care, the initiative seeks to cut preventable hospitalizations and lower costs for high-acuity patients. For the growing population living with chronic kidney disease, this could open new, personalized options for treatment and stability at home—addressing a consistent challenge in value-based care.
End-of-life care statistics by care, conditions and illness (2026)
02/03/26 at 03:00 AM[Worldwide] End-of-life care statistics by care, conditions and illness (2026) Market.us Media; by Samruddhi Yardi; 2/2/26 Each year, an estimated 56.8 million people, including 25.7 million in the last year of life, are in need of palliative care. Worldwide, only about 14% of people who need palliative care currently receive it. ... As society continues to grapple with evolving views on life and death, the commitment to compassionate, personalized, and respectful end-of-life care remains paramount. Embracing this philosophy ensures that every individual is allowed a dignified and meaningful conclusion to their life’s journey.
How to responsibly use AI in palliative care and hematologic malignancies
02/03/26 at 03:00 AMHow to responsibly use AI in palliative care and hematologic malignancies CancerNetwork; podcast by Ram Prakash Thirugnanasambandam, MBBS; 2/2/26 In a conversation with CancerNetwork®, Ram Prakash Thirugnanasambandam, MBBS, discussed the evolving roles that artificial intelligence (AI)–based tools may play in palliative care and the management of different hematologic malignancies. ... According to Thirugnanasambandam, implementing AI into one’s workflow may help accurately predict disease subtypes and burdens among patients with leukemia, lymphoma, or multiple myeloma. ... Thirugnanasambandam also discussed some of the ethical considerations surrounding the growth of AI-based tools, highlighting information privacy concerns and potentially biased datasets as notable issues with these platforms. Although AI may assist with decision-making, Thirugnanasambandam stated that it ultimately cannot replace a human’s nuanced clinical judgment and empathy.
Drivers of disease-specific end-of-life disparities
02/02/26 at 03:00 AMDrivers of disease-specific end-of-life disparities Hospice News; by Holly Vossel; 1/30/26 ... Racial and ethnic disparities persist among underserved patient populations with dementia, who have a stronger likelihood of dying without awareness or access to hospice, recent research has found. Clinicians may play a vital role in moving the needle forward. Nearly 260, 000 Black, Hispanic and white Medicare decedents with dementia-related conditions were recently examined in a new study, which was published in the Journal of the American Medical Association (JAMA) Health Forum. Editor's Note: We posted this study in our Saturday Research newsletter, 12/27/25, End-of-life care for older adults with dementia by race and ethnicity and physicians’ role. This article gives more practical descriptions and applications for its results.
Concurrent care and equity: Addressing palliative care gaps for African American men in rural communities with a serious respiratory illness
01/31/26 at 03:35 AMConcurrent care and equity: Addressing palliative care gaps for African American men in rural communities with a serious respiratory illnessAmerican Journal of Hospice & Palliative Medicine; by Cathy L. Campbell; 12/25Hospice and palliative care are often hard to access for African Americans (AA) living in rural areas with serious respiratory illnesses. Under the Medicare Hospice Benefit, patients must stop curative or life-sustaining treatments for their terminal illness, which limits options for concurrent care. This is a major challenge for AA men, whose average life expectancy is 67.8 years—about 10 years shorter than the national average. They also experience more care transitions in the last 6 months of life compared to White and Hispanic patients. These frequent transitions show how fragmented the health system is and how it often fails AA families. Using intersectionality and a vignette, this paper explores how overlapping factors—lived experience as AA man, rural location, and serious illness—affect access to palliative care.
Exploring the anxiety, depression and perceived burden in advanced cancer: A longitudinal view on patients and caregivers
01/31/26 at 03:15 AM[Australia] Cancer and dementia incidence are strongly correlated worldwide: Evidence from cross-national regression analyses
01/31/26 at 03:05 AM[Australia] Cancer and dementia incidence are strongly correlated worldwide: Evidence from cross-national regression analysesFuture Science OA; by Wenpeng You, Brendon J Coventry, Maciej Henneberg; 12/25Cancer and dementia are two major health problems affecting millions of people around the world. Countries with higher cancer rates almost always have higher dementia rates. Even after we accounted for income, life expectancy, and other social factors, cancer remained one of the strongest predictors of dementia. These findings suggest that cancer and dementia share many of the same underlying causes, such as aging, chronic inflammation, lifestyle habits, and changes that come with economic development. Understanding these shared patterns can help countries plan for future healthcare needs.
Integrating psychiatric and hospice services: Legal and clinical considerations for involuntary commitment in multimorbid end-of-life care
01/30/26 at 03:00 AMIntegrating psychiatric and hospice services: Legal and clinical considerations for involuntary commitment in multimorbid end-of-life care American Journal of Hospice and Palliative Medicine; by Ilana Marmershteyn, BS, Darian Peters, BS, Victor Milev, BS, Mario Jacomino, MD, MPH, and George Luck, MD, FAAHPM; 1/28/26 Multimorbid patients at the end-of-life face complex medical, psychosocial, and psychiatric challenges. Hospice care aims to address physical, emotional, and spiritual needs; however, psychiatric comorbidities, particularly acute crises, remain under-recognized and inconsistently managed. The intersection of psychiatric intervention, hospice care, and legal frameworks such as involuntary commitment presents significant clinical and ethical challenges.
Patients with terminal blood cancer stress need for transfusion access in hospice care, survey finds
01/30/26 at 03:00 AMPatients with terminal blood cancer stress need for transfusion access in hospice care, survey findsHematology Advisor; by Joantahn Goodman, MPhil; 1/28/26 Patients with blood cancer eligible for hospice care emphasize the importance of access to transfusion over other services, according to research published in JAMA Network Open. The survey-based study confirms that, among patients with an estimated life expectancy of 6 months or less, routine hospice services are perceived of less value than transfusion access — suggesting that palliative transfusion availability should be incorporated into hospice care universally, the authors noted in their report.
Stroke survivors in DFW find new hope with Sovereign Hospice Home Care
01/27/26 at 03:00 AMStroke survivors in DFW find new hope with Sovereign Hospice Home Care Holliston Town News, Aubrey, TX; by Sovereign Hospice; 1/26/26 Stroke survivors and their families often encounter unexpected challenges ... Sovereign Hospice in Aubrey, Texas, addresses these complex needs through targeted palliative care programs designed specifically for post-stroke complications. ... Post-stroke pain affects approximately 30% of survivors, manifesting as headaches, muscle spasticity, or neuropathic sensations. Fatigue represents another common issue, with many patients reporting exhaustion after minimal activity. Depression occurs in roughly one-third of stroke survivors, creating additional barriers to recovery.
10 things I learned after 10 years with ovarian cancer
01/26/26 at 03:00 AM10 things I learned after 10 years with ovarian cancer Cure; by Kelly Irvin; 1/22/26 My birthday was January 20. ... I received my stage 4 ovarian cancer diagnosis on Jan. 16, 2016. ... So here I am still alive ten years later on my 68th birthday. ... I feel I’m allowed to share what I wish my younger self had known when I received my diagnosis. Counting down to number one, here are my lessons learned:
Husband with Parkinson's was admitted into at-home hospice program and has dramatically improved. Have others experienced this?
01/26/26 at 03:00 AMHusband with Parkinson's was admitted into at-home hospice program and has dramatically improved. Have others experienced this? Aging Care; by Klwolf; 1/21/26 My DH has Parkinson’s that has been getting progressively worse for months. In early December we had him assessed for hospice and he was admitted. Since then, he’s improved dramatically. Has anyone else experienced dramatic improvement AFTER hospice enrollment? The hospice staff simply shrugs and says this sometimes happens and that we need to be prepared for him to revert back to his previous state. Editor's Note: Many clinicians have seen individuals improve after hospice enrollment, often due to better symptom control, reduced stress, or consistent interdisciplinary care. The concern here is not the improvement itself, but the hospice team’s reported response. A shrug can feel dismissive to families already living with uncertainty. How do we teach teams to communicate about improvement—honoring hope while preparing families with clarity, compassion, and trust?
Palliative care in pediatric phase I oncology trials: A scoping review
01/24/26 at 03:45 AMPalliative care in pediatric phase I oncology trials: A scoping reviewPediatric Blood & Cancer; by Andrea Cuviello, Harisankeerth Mummareddy, Alanis N. Gomez Martinez, Holly Spraker-Perlman, Allison Uber, Jordan Wrigley, Erica C. Kaye; 12/25Clinical trials, particularly Phase I trials that test drug safety and feasibility, are imperative to advance outcomes for children with cancer. These trials, however, pose risks for increased symptom burden and suffering. Early integration of palliative care (PC) during Phase I trial enrollment offers a potential reduction in suffering and improvement in quality of life. PC integration was associated with earlier hospice enrollment, increased home and hospice deaths, decreased hospitalizations and intensive care unit utilization, improved care coordination, and better symptom management.
GITalk: Communication skills training for gastroenterology fellows improves self-assessed preparedness for serious illness conversations
01/24/26 at 03:15 AMExpanding the boundaries of palliative care: Diseases of the nervous system and survival prognosis in home-based programs
01/24/26 at 03:00 AMExpanding the boundaries of palliative care: Diseases of the nervous system and survival prognosis in home-based programsAmerican Journal of Hospice & Palliative Medicine; by Mônica Isaura Corrêa, Igor de Oliveira Claber Siqueira, Sonia Souza, Eduardo Bruera, Ana Paula Drummond-Lage; 12/25Home-based palliative care (HBPC) is increasingly recognized as an essential strategy for managing patients with non-oncologic and life-limiting conditions. However, prognostic factors influencing survival in this population remain underexplored. Diseases of the nervous system (DNS) were the most frequent referral diagnoses [in this study] (32.3%). Patients with Alzheimer’s disease and related dementias demonstrated longer survival than those with other DNS or no DNS diagnoses ... While PPS [Palliative Performance Scale] remains a useful tool, its discriminatory capacity was modest, underscoring the need for refined prognostic models in non-oncologic palliative care.
A different kind of care: The compelling case for palliative care in advanced kidney disease
01/21/26 at 03:00 AMA different kind of care: The compelling case for palliative care in advanced kidney disease docwirenews; by Keightley Amen; 1/20/26 Advanced kidney disease requires some of the most complex care in medicine due to medical management, comorbid conditions, symptom burden, patient and family psychosocial needs, difficult conversations, and advance care planning. Despite the significant coordination needed, care for this patient population is often more fragmented, with less access to supportive services, than for people with other chronic, life-limiting illnesses.
